PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

diltiazem Side Effects

The reactions most often reported to the FDA for diltiazem (also sold as Cardizem, Tiazac), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

33,620
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2003 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of diltiazem come from 33,620 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 33,620 reports to the FDA Adverse Event Reporting System (FAERS) for diltiazem (Cardizem): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

33,620

Reports Mentioning Death

4,917

14.6% of reports — not proof the medicine caused the death

Hospitalizations

14,360

42.7% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DYSPNOEA
3,202
FATIGUE
2,638
NAUSEA
2,372
PAIN
2,365
DIZZINESS
2,091
DIARRHOEA
2,045
FALL
1,954
HEADACHE
1,929
ATRIAL FIBRILLATION
1,754
ASTHENIA
1,705
PNEUMONIA
1,605
ARTHRALGIA
1,548
HYPOTENSION
1,494
PAIN IN EXTREMITY
1,449
MALAISE
1,411
VOMITING
1,381
WEIGHT DECREASED
1,345
PRURITUS
1,279

Who Reports Side Effects

Gender Distribution

Female 20,122 (64%)
Male 11,326 (36%)
Unknown 59

Age Distribution

0-17 101 (0%)
18-44 1,642 (7%)
45-64 6,878 (30%)
65-74 6,680 (29%)
75+ 7,764 (34%)

Reporting Trend by Year

2003 2025

Reactions in Death Reports

Top reactions reported in 4,917 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 1,209
DYSPNOEA 679
FATIGUE 555
DIARRHOEA 526
DIZZINESS 506
NAUSEA 482
PNEUMONIA 462
HEADACHE 458
COMPLETED SUICIDE 451
DECREASED APPETITE 449
VOMITING 444
PAIN 443
PYREXIA 420
ARTHRALGIA 415
ASTHENIA 409
INJURY 407
PRURITUS 401
CONDITION AGGRAVATED 366
HYPERTENSION 356
ANXIETY 355

Reactions in Hospitalization Reports

Top reactions in 14,360 reports where hospitalization was an outcome.

Reaction Reports
DYSPNOEA 1,868
PAIN 1,451
ATRIAL FIBRILLATION 1,358
FALL 1,333
PNEUMONIA 1,268
FATIGUE 1,183
HYPOTENSION 1,162
NAUSEA 993
ASTHENIA 953
DIARRHOEA 928
DIZZINESS 882
PAIN IN EXTREMITY 843
CARDIAC FAILURE CONGESTIVE 840
CHEST PAIN 808
PYREXIA 755
CONDITION AGGRAVATED 754
CONSTIPATION 746
HEADACHE 729
MYOCARDIAL INFARCTION 725

Compare diltiazem vs acebutolol →

What the FAERS Data Reveals About diltiazem Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 33,620 voluntary reports linked to diltiazem and its brand equivalents (Cardizem, Tiazac), spanning 2003 through 2025. Of those, 4,917 (14.6%) listed death as an outcome and 14,360 (42.7%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 64% were female and 36% male; age distribution skews toward 75+, with 7,764 reports in that bracket. The single most reported reaction is dyspnoea with 3,202 submissions, followed by fatigue and nausea.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.